219 related articles for article (PubMed ID: 136010)
1. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
Trulson ME; Ross CA; Jacobs BL
Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
[TBL] [Abstract][Full Text] [Related]
2. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
Trulson ME; Eubanks EE; Jacobs BL
J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
[TBL] [Abstract][Full Text] [Related]
3. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
Sloviter RS; Drust EG; Damiano BP; Connor JD
J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
[No Abstract] [Full Text] [Related]
4. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
Burris KD; Breeding M; Sanders-Bush E
J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
[TBL] [Abstract][Full Text] [Related]
5. Specificity of a rat behavioral model for serotonin receptor activation.
Sloviter RS; Drust EG; Connor JD
J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
[TBL] [Abstract][Full Text] [Related]
6. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
Larson AA; Chinn C; Proudfit HK; Anderson EG
J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
[TBL] [Abstract][Full Text] [Related]
7. LSD and CNS transmission.
Aghajanian GK
Annu Rev Pharmacol; 1972; 12():157-68. PubMed ID: 4339014
[No Abstract] [Full Text] [Related]
8. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
[TBL] [Abstract][Full Text] [Related]
9. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
Boullin DJ; Green AR
Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
[No Abstract] [Full Text] [Related]
10. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
Trulson ME; Jacobs BL
Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
[No Abstract] [Full Text] [Related]
11. Behavioral and biochemical effects of para-methoxyphenylethylamine.
Hwang EC; Van Woert MH
Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):419-31. PubMed ID: 461968
[TBL] [Abstract][Full Text] [Related]
12. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.
Dwoskin LP; Sparber SB
J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279
[TBL] [Abstract][Full Text] [Related]
13. QSAR of agents involved in serotonin and LSD binding sites.
Chan YL; Lien EJ; Shih JC
NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
[No Abstract] [Full Text] [Related]
14. Evidence that serotonin mediates some behavioral effects of amphetamine.
Sloviter RS; Drust EG; Connor JD
J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
[TBL] [Abstract][Full Text] [Related]
15. [The effect of several psychotropic substances on brain structure].
Popova EN; Krivitskaia GN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(7):1064-9. PubMed ID: 1210984
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.
Marona-Lewicka D; Kurrasch-Orbaugh DM; Selken JR; Cumbay MG; Lisnicchia JG; Nichols DE
Psychopharmacology (Berl); 2002 Oct; 164(1):93-107. PubMed ID: 12373423
[TBL] [Abstract][Full Text] [Related]
17. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
Burris KD; Sanders-Bush E
Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
[TBL] [Abstract][Full Text] [Related]
18. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
King AR; Martin IL; Melville KA
Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and neurochemical effects of apomorphine in the cat.
Trulson ME; Crisp T
Eur J Pharmacol; 1982 Jun; 80(4):295-309. PubMed ID: 6213419
[TBL] [Abstract][Full Text] [Related]
20. [Effect of long-term lithium treatment on serotonin syndrome in rats].
Yamawaki S; Yanagawa K; Hotta I; Uchitomi Y
Yakubutsu Seishin Kodo; 1986 Jun; 6(2):247-52. PubMed ID: 3096011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
